Literature DB >> 8262861

Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori.

S L Lacey1, S F Moss, G W Taylor.   

Abstract

The development of metronidazole resistance in Helicobacter pylori has become an important factor in the clinical use of this drug in the treatment of gastritis and peptic ulcers. The mechanism for the development of resistance is not known but may involve factors which influence metronidazole uptake and metabolism. In this study, a simple and reliable HPLC assay for metronidazole was developed and the uptake of the drug from broth cultures of both resistant and sensitive strains of H. pylori was investigated. Resistance to metronidazole was determined by the E test as well as plate and broth assays. In the presence of the antibiotic (approximately 10 mg/L), metronidazole-sensitive strains were killed within 24 h and there was a concomitant fall in the concentration of metronidazole in the broth. In contrast, the killing of resistant strains of H. pylori was associated with < 10% loss of antibiotic from broth. These differences in metronidazole uptake are ascribed to alterations in the mechanisms of action of the drug in sensitive and resistant strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262861     DOI: 10.1093/jac/32.3.393

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.

Authors:  A A van Zwet; J C Thijs; B de Graaf
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

2.  In vitro activities of new quinolones against Helicobacter pylori.

Authors:  M Carbone; M T Fera; V Cecchetti; O Tabarrini; E Losi; V Cusumano; G Teti
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

3.  Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; A Björkman; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.

Authors:  Khalid H Ibrahim; Brent W Gunderson; Elizabeth D Hermsen; Laurie B Hovde; John C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.

Authors:  P S Hoffman; A Goodwin; J Johnsen; K Magee; S J Veldhuyzen van Zanten
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

6.  Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori.

Authors:  J Y Jeong; A K Mukhopadhyay; D Dailidiene; Y Wang; B Velapatiño; R H Gilman; A J Parkinson; G B Nair; B C Wong; S K Lam; R Mistry; I Segal; Y Yuan; H Gao; T Alarcon; M L Brea; Y Ito; D Kersulyte; H K Lee; Y Gong; A Goodwin; P S Hoffman; D E Berg
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

7.  Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by Lactobacilli in vitro.

Authors:  N W McLean; J A McGroarty
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

Review 8.  Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.

Authors:  Evariste Tshibangu-Kabamba; Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 46.802

9.  Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance.

Authors:  Gil M Penuliar; Kumiko Nakada-Tsukui; Tomoyoshi Nozaki
Journal:  Front Microbiol       Date:  2015-05-05       Impact factor: 5.640

10.  Proteomic signatures of metronidazole-resistant Trichomonas vaginalis reveal novel proteins associated with drug resistance.

Authors:  Hsin-Chung Lin; Lichieh Julie Chu; Po-Jung Huang; Wei-Hung Cheng; Yu-Hsing Zheng; Ching-Yun Huang; Shu-Wen Hong; Lih-Chyang Chen; Hsin-An Lin; Jui-Yang Wang; Ruei-Min Chen; Wei-Ning Lin; Petrus Tang; Kuo-Yang Huang
Journal:  Parasit Vectors       Date:  2020-06-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.